Cargando…

Systemic and regional effects of levosimendan and arginine–vaopressine in endotoxin-treated rabbits

Detalles Bibliográficos
Autores principales:	Kaskos, H, Faivre, V, Losser, M, Payen, D, Mebazaa, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099669/ http://dx.doi.org/10.1186/cc2549

Ejemplares similares

Hemodynamic effects of levosimendan after surgery in LPS pretreated rabbits
por: Faivre, V, et al.
Publicado: (2003)

Sublingual microcirculatory response to fluid challenge in septic shock patients
por: Losser, M, et al.
Publicado: (2004)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Dose-response of arginine-vasopressin (AVP) on blood pressure (MAP), renal macro and micro cortical and medullary flowsin anesthetized rabbits
por: Albert, M, et al.
Publicado: (2001)

Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

Levosimendan: experience of an adult ICU
por: Lippett, S, et al.
Publicado: (2006)

Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009)

Levosimendan versus dobutamine in cardiac surgery
por: Delgado-Amaya, MD, et al.
Publicado: (2015)

Levosimendan in trauma patients with acute cardiac failure
por: Afonin, AN, et al.
Publicado: (2011)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Levosimendan versus dobutamine in Tako-tsubo cardiomyopathy
por: Righetti, FR, et al.
Publicado: (2013)

Levosimendan in myocardial depression due to severe sepsis
por: Malik, M, et al.
Publicado: (2007)

Use of levosimendan in myocardial dysfunction due to sepsis
por: Vaitsis, J, et al.
Publicado: (2009)

Haemodynamic effects of levosimendan following cardiac surgery
por: Slezina, A, et al.
Publicado: (2009)

Utilization of levosimendan in the cardiac ICU: case series
por: Filipescu, D, et al.
Publicado: (2009)

Hemodynamic and volumetric response to levosimendan in critical care patients
por: Turani, F, et al.
Publicado: (2004)

Levosimendan in critically ill adults: a utilisation review
por: Aron, J, et al.
Publicado: (2013)

Levosimendan use in critical care - a case series
por: Gibson, C, et al.
Publicado: (2015)

Measuring endotoxin with newly developed endotoxin scattering photometry
por: Kase, Y, et al.
Publicado: (2008)

Levosimendan reduces pulmonary vascular resistance: clinical echocardiographic study
por: Nalos, M, et al.
Publicado: (2004)

Combined effects of ivabradine with dobutamine or levosimendan in isolated perfused hearts
por: Konrad, D, et al.
Publicado: (2013)

Levosimendan in patients with acute cardiogenic shock, not responders to conventional therapy
por: Vetrugno, L, et al.
Publicado: (2007)

Effects of levosimendan and inhaled nitric oxide on microcirculation in septic shock
por: Morelli, A, et al.
Publicado: (2009)

Hemodynamic effects of levosimendan in patients with low-output heart failure
por: Gharsallah, H, et al.
Publicado: (2008)

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

Changes in procalcitonin in septic shock patients treated with endotoxin adsorption therapy
por: Ikeda, T, et al.
Publicado: (2005)

Endotoxin assay with endotoxin scattering photometry is one of the diagnostic markers of sepsis
por: Kase, Y, et al.
Publicado: (2010)

Hemodynamic effects of the new calcium sensitiser levosimendan in cardiosurgical ICU patients
por: Iasonidou, C, et al.
Publicado: (2004)

Influence of temperature on the cardiac action of dobutamine and levosimendan in isolated perfused hearts
por: Aldenhoff, U, et al.
Publicado: (2013)

Retrospective study of proarrhythmic effects of levosimendan during the therapy of heart failure
por: Zima, E, et al.
Publicado: (2007)

Hemodynamic and echographic effects of levosimendan in patients with cardiogenic shock refractory to catecholamines
por: Labbene, I, et al.
Publicado: (2006)

Levosimendan does not improve resuscitation success after hypovolemic cardiac arrest
por: Semenas, E, et al.
Publicado: (2008)

Levosimendan: use, cost-effectiveness and outcome in a tertiary cardiothoracic centre
por: Ranjan, A, et al.
Publicado: (2015)

Levosimendan in the emergency department: a useful tool to improve cellular perfusion
por: Devia, G, et al.
Publicado: (2015)

Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in compensated chronic heart failure patients treated with levosimendan
por: Figueiredo, EJ de Almeida, et al.
Publicado: (2007)

Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in decompensated chronic heart failure patients treated with levosimendan
por: Ferri, MB, et al.
Publicado: (2006)

Effects of levosimendan on renal function in septic shock: a case–control study
por: Morelli, A, et al.
Publicado: (2009)

Levosimendan therapy does not improve survival of post-resuscitation cardiogenic shock patients
por: Soos, P, et al.
Publicado: (2009)

Early experience with levosimendan in children with low-output syndrome after cardiac surgery
por: Galas, F, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_tpj26litar2p1f4p4mnc7lg42t